Metly is an AI‑driven pharma intelligence platform that continuously scans regulatory filings, clinical trial registries, patents, SEC disclosures, and other market signals, integrating them with a company’s internal data. Users can query the system in natural language to receive ranked, contact‑ready asset opportunities and real‑time competitor alerts, while the platform automatically updates strategic deliverables such as portfolio decks and generics trackers. Expert analysts validate the AI‑generated insights, ensuring accurate, actionable intelligence for business development, licensing, and competitive strategy teams.
Funding
Funding not disclosed
Founders
Product
Problem
Pharmaceutical companies spend weeks manually gathering fragmented regulatory filings, clinical trial data, and partnership signals, leading to delayed and incomplete intelligence for business development, licensing, and competitive strategy.
Solution
Metly delivers an AI‑driven pharma intelligence platform that continuously scans external sources—including regulatory agencies, clinical trial registries, patents, SEC filings, and market signals—and integrates them with a company’s internal data. Users can query the system in natural language to surface ranked, contact‑ready asset opportunities or receive real‑time alerts when competitors launch relevant trials or filings. The platform automatically updates deliverables such as portfolio decks, generics trackers, and erosion forecasts, ensuring that strategic documents remain current without manual effort. Expert analysts validate the AI‑generated insights, providing contextual commentary that aligns with therapeutic‑area expertise. This combination of automated data collection, synthesis, and expert validation enables faster, more accurate decision‑making across BD, licensing, and competitive intelligence functions.
Target Audience
Primary users are business development, licensing, portfolio strategy, and competitive intelligence teams within pharmaceutical and biotech companies that require timely, comprehensive market intelligence.
Features
- Natural‑language search across regulatory filings, clinical trial databases, patents, SEC disclosures, and internal systems
- Real‑time competitor monitoring with alerts that include impact assessments for specific portfolios
- Automated updating of strategic deliverables (e.g., deck slides, generics trackers, erosion forecasts) as new signals appear
- Ranked, contact‑ready asset opportunities with therapeutic‑area contextualization
- Integration of internal data sources (Veeva, IQVIA, internal repositories) with external market signals
- Expert analyst layer that validates AI outputs and adds strategic commentary